3th Advisory Board Meeting

Butantan Institute - 11/27/2018

3th Advisory Board Meeting

Dates: 22th - 23th November 2018

Place: Av. Vital Brasil, 1500
Butantã - São Paulo/SP
Espaço Centro de Difusão Científica (CDC)

Access the agenda of the event


Tips and Tools for Successful Publication in High Impact journals: Science Family jornals

Butantan Institute - 10/30/2018

Tips and Tools for Successful Publication in High Impact journals: Science Family jornals

On October 25th and 26th (CENTD received) we received the chief editor of Science Advances journal, Philippa Benson, PhD. The (illustrious) visit featured a lecture, a workshop and a scientific writing workshop.

These activities were centered around the main reasons for rejection of articles in high-impact journals and tips to prevent rejection. Also, Philippa talked about writing articles for journals like Science, denoting aspects of the publisher routine and what they are most aware of when evaluating the work.

The participants had the opportunity to resolve doubts and discuss scientific production; as well as receive directions about the construction of their scientific articles (in progress), aiming to approach Brazilian authors and promote collaborations to improve the acceptance rates of articles in high-impact journals.


Winter Course: Pain and Intracellular Signaling (3rd Edition)

Instituto Butantan - 08/02/2018

Winter Course: Pain and Intracellular Signaling (3rd Edition)

CENTD, in partnership with the Laboratory of Pain and Signaling and the team of Butantan Institute courses held last week the 3rd Course of Pain and Intracellular Signaling.

The course lasted a week and covered topics such as epidemiology and pharmacology of pain, development of drugs and use of toxins as tools for the discovery of new analgesics. In a dynamic and relaxed way, the students had theoretical-practical classes, participated in gymkhana and counted on a digital platform for content reinforcement.

"The idea is to deepen the subject addressed in the universities, to develop the scientific interest in the area of pain and to bring the university students closer to Butantan Institute", comments Vanessa Zambelli, coordinator of the course.

The course had 25 students from several locations such as São Paulo, Bauru, São Carlos, Manaus, Fortaleza and Bahia.

For Devlyn Pivoloto, 30, graduated in Physiotherapy and a Pharmacy student, studying pain is complex, but the course paid off. "I'm enjoying the experience, through the interactions and gymkhana, we've been able to learn in a light and easy way," said Devlyn.


Paper Anniversary of CENTD

Butantan Institute- 07/22/2018

Paper Anniversary of CENTD

In an event that involved science, art and innovation, CENTD (Centre of Excellence in New Target Discovery) celebrated on the morning of last Friday (20) its "paper anniversary", representing a year of partnership between Butantan Institute , Fapesp (Fundação de Amparo à Pesquisa do Estado de São Paulo) and GSK (GlaxoSmithKline). The presence of specialists in research and innovation from the pharmaceutical industry, the commemorative event brought together about 70 Butantan collaborators and scientists

"Today we are celebrating a year of very intense work, committed to the challenge of finding new molecular targets that could produce new drugs," said Ana Marisa Chudzinski-Tavassi, coordinator and principal investigator of the project.

At the opening, Ana Marisa highlighted the current structure available for research, such as state-of-the-art types of equipments that allows the team to discover new uses for poisons and animal secretions. At the beginning the platform began with four people and currently have 80 employees, all trained to operate the technology of the laboratories.

Throughout its first year of existence, the platform also carried out courses, workshops, educational projects, specialized labor training (masters, doctoral students and technicians) and publications. The actions aim to broaden the knowledge and perspectives of researchers on the potential of their work, ideas and results. CENTD was inaugurated on July 21, 2017 and seeks to find in the venom of poisonous animals, elements that allow the creation of new drugs for inflammatory diseases such as rheumatoid arthritis, metabolic syndrome and neurodegenerative diseases.

The event was attended by Fernando Queiroz Cunha, professor of Pharmacology at the Faculty of Medicine of Ribeirão Preto (FMRP-USP) and Ricardo Remer, a postgraduate professor in Strategic Management of Technological Innovation at UNICAMP, who shared their ideas with those present at the event

For Fernando Queiroz, it is in the hands of young researchers the mission to continue with studies resulting in innovation for the production of new drugs. "Today, working with technology means having scientists working with industry and inside industry," he said. In his lecture "Current and Future Perspectives in Controlling Arthritis," the expert presented the current treatments available for the control of rheumatoid arthritis, inflammatory disease of joints and cartilage.

A professional with experience in patents, intellectual property and technology transfer, Ricardo Remer showed how it is possible to think about scientific research strategically. "Rich country is a country that exports knowledge in the form of patent," he said, adding that the challenge is to transform the intellectual property into wealth, that is, to market the knowledge. "If you treat research strategically from the beginning, you will increase the final value of your results," he explained.

The celebration included the opening of an exhibition of watercolor illustrations by the artist Lilian Arbex. In the pictures, the watercolor artist portrayed some of the iconic buildings of the Butantan Institute, such as the Library, Casa Afrânio de Amaral and the first masonry building of the institution, where the CENTD platform currently stands.

The exhibition will be installed in the exhibition space of the CDC, next to Paiol, until August 3 and is open to all.

Lilian holds a degree in Pharmacy, Biochemistry and Industrial Design / Visual Programming, has a postgraduate degree in Graphic Design, is responsible for the International Watercolor Society Brazil and was the Director of the Brazilian Association of Watercolor and Art on Paper (ABA).

Some of his paintings and engravings belong to private and public collections, such as Pinacoteca do Estado de São Paulo and National Library of Rio de Janeiro, Banco Bradesco, Secretary of Sports of São Paulo, among others.

By Caroline Roque (Communication support of the Butantan Institute)

Source: Butantan News n.30


Workshop on Structuring a Business Model – starting from the institutional project

Butantan Institute - 07/04/2018

Workshop on Structuring a Business Model – starting from the institutional project

Ana Marisa Chudzinski-Tavassi
Marcus Salusse
Cintia Retz Lucci

Dates: 06/20, 06/27 and 08/02
Duration: 16h
Modality: Presential
Localization: Centro de Difusão Cientifica (CDC) and Library (Room Cezário Motta)
Public: Butantan Institute and Butantan Foundation

The Workshop aims to assist participants in understanding and to structure a Business Model that allows them to reflect on initiating, expanding or maintaining a scientific / technological research, according to its relevance and impact, for public health and the health market.

Encourage researchers to structure a Business Model for the projects they are developing, based on the premises that IBU has defined for this area.


MBA Health Management of Innovation of Instituto Butantan and Biominas Brasil announce partnership focused on education in entrepreneurship

Butantan Institute - 07/04/2018

MBA Health Management of Innovation of Instituto Butantan and Biominas Brasil announce partnership focused on education in entrepreneurship

The Butantan Institute, one of the largest research centers in Brazil, and Biominas Brazil announce on Tuesday (3), an important partnership in entrepreneurship education and innovation in the health area.

Biominas is a private institution active in the field of innovation and entrepreneurship in the life sciences sector.

Through the partnership, Biominas and Butantan, it will be possible to expand the vacancies for researchers, entrepreneurs and professionals in the MBA in Health Innovation Management, already successfully promoted by Butantan in recent years, and recognized as one of the best courses in innovation in the country.

At the same time, the partners will develop and offer a wide range of new courses and modules in Distance Learning format through the Butantan online platform, using the expertise and experience of both institutions.

Biominas will work with Butantan to disseminate the courses in its extensive network of contacts among the main stakeholders in the health, life sciences and biotechnology sector and in its events and activities.

The general coordinator of the MBA, Ana Marisa Chudzinski Tavassi, explains that Biominas has an extensive network of contacts with researchers in the area of innovation and health, contributing to the dissemination and growth of the Butantan course. With the dismemberment of the MBA and the availability of classes through the Distance Learning modality, access for those who do not live in São Paulo will be easier. "These online courses can be offered separately and they enter the curriculum as a specialization," said Ana Marisa.

Through the initiative, Biominas and Butantan contribute significantly to the dissemination of information, training of human resources and development of health innovation in the country.

"The fact that Biominas accepted this partnership, for us, was of extreme significance," said Linda Bernardes, educational and Distance Education coordinator for Butantan's MBA.

The Butantan MBA has been underway for five years, has trained about 100 professionals and provides full scholarships for senior level employees who work in the health area or who want to work on innovative projects. Although applications for scholarships closed last Friday, the course offers new vacancies whenever new classes are about to open (follow the MBA news on the intranet and through Butantan News).

By Adriana Matiuzo (Communication advisor of the Butantan Institute)

Source: Butantan News n.27


Butantan receives British minister

Butantan Institute - 04/24/2018

Butantan recebe ministra britânica

British Minister: Elizabeth Truss; Principal investigators: Denise Tambourgi (vice-coordinator), Ana Maria Chudzinski-Tavassi (coordinator).

On April 11, the British Minister Elizabeth Truss and her entourage visited the Butantan Institute. UK's chief Treasury Secretary, Truss was received at the CENTD (Centre of Excellence in New Target Discovery) by the Board, as well as introduced to the operations in the center when visiting the platform!

*Source: Butantan News Report n.15


President of GSK Brasil Farma visited the Centre of Excellence in New Target Discovery (CENTD)

Butantan Institute - 03/20/2018

President of GSK Brasil Farma visited the Centre of Excellence in New Target Discovery (CENTD)

Principal Investigators: Ana Maria Chudzinski-Tavassi (coordinator), Catarina Teixeira, Denise Tambourgi (vice-coordinator), Irina Kerkis, Olga Ibañez, Yara Cury, GSK Brasil Farma President Alexey Kolchin, Executive Manager: Isabel Batista, Scientific Broadcasting: Vanessa Zambelli.

The president of GSK Brasil Farma, Alexey Kolchin visited the Centre of Excellence in New Target Discovery (CENTD) on Wednesday (14). During the visit Dr. Kolchin met key researchers and CENTD facilities. The purpose of the visit was to know more about the project developed by CENTD, aiming for closer ties and new partnerships with the Institution.

CENTD is a partnership between the Butantan Institute and the Foundation for Research Support of the State of São Paulo (FAPESP) and the GlaxoSmithKline Pharmacy (GSK), and aims to discover and validate therapeutic targets for immune-based inflammations. In this project, venoms and animal secretions are used in the validation of therapeutic targets, opening the way for the development of new drugs


Lecture - "Importance of the patent system"

Butantan Institute - 10/23/2017

Lecture -

The president of INPI (National Institute of Industrial Property), Luiz Otávio Pimentel (photo), participated as a lecturer on Wednesday, October 18, of the Executive Training Course for Managers of Health Innovation of the Butantan Institute.

Pimentel presented the INPI, spoke of his management at the head of this institution, discussed with the students the intellectual property system and the patents in the health area.

The invitation was extended to the entire Butantan community, which was able to discuss with the guest the current patent system of the country, in addition to asking questions and giving suggestions about the current policy.

The Executive Training Course for Managers of Health Innovation of the Butantan Institute is an initiative of the Directorate of Innovation, whose objective is to spread this culture in the Institute, aiming at the developing people prepared to suggest improvements and innovations, together with a set of new visions, procedures and resources that will undoubtedly boost institutional growth.


Butantan inaugurates the CENTD

Butantan Institute - 07/21/2017

Butantan inaugurates the CENTD

Last Friday, July 21, the Centre of Excellence in New Target Discovery (CENTD) was inaugurated at the Butantan Institute. The project is a partnership of the Institute with the Foundation for Research Support of the State of São Paulo (FAPESP) and the pharmaceutical

About 180 people were present, among authorities, guests, researchers, employees and collaborators of the Institute and the Butantan Foundation.

The panel was composed by Dr. Ana Marisa Chudzinski Tavassi, Coordinator of CENTD; Mr. Carlos Henrique Brito, Scientific Director of FAPESP; Mr. Isro Gloger, Director of GSK's Trust in Science Program; Ms. Joanna Crellin, British Consul General in São Paulo; Mr Wasim Mir, Minister Counselor of United Kingdom Diplomatic Mission; Prof. Dr. Dimas Tadeu Covas, Director of Butantan Institute; and Dr. David Uip, Health Secretary of State of São Paulo.

The goal of CENTD is to identify molecular targets and signaling pathways involved in inflammatory diseases such as osteoarthritis, rheumatoid arthritis, cancer and neurodegenerative diseases, through poisons, toxins, and molecules isolated from various animal secretions, as well as their peptides byproducts.

The partnership between Butantan, GSK and FAPESP were signed at the end of 2015 for a period of five years. The coordination of CENTD is by Ana Marisa Chudzinski-Tavassi, a researcher of the Butantan Institute, which counts with the collaboration of several scientists, comprising six main lines of research.

The Centre of Excellence in partnership with GSK follows the rules of the FAPESP Program to Support Research in Partnership for Technological Innovation (PITE) and the Engineering Research Centers supported by the Foundation, to carry out long-term research with companies, enabling the shared generation of knowledge in areas of common interest, with a significant potential for results application.

Access the Information